RGFP966 structure
|
Common Name | RGFP966 | ||
---|---|---|---|---|
CAS Number | 1396841-57-8 | Molecular Weight | 362.40000 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C21H19FN4O | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of RGFP966(E,E)-RGFP966 is a selective and CNS permeable HDAC3 inhibitor that can be used for the research of Huntington’s disease[1]. |
Name | 2-Propenamide, N-(2-amino-4-fluorophenyl)-3-[1-[(2E)-3-phenyl-2-propen-1-yl]-1H-pyrazol-4-yl]-, (2E) |
---|---|
Synonym | More Synonyms |
Description | (E,E)-RGFP966 is a selective and CNS permeable HDAC3 inhibitor that can be used for the research of Huntington’s disease[1]. |
---|---|
Related Catalog | |
Target |
HDAC3[1] |
References |
Molecular Formula | C21H19FN4O |
---|---|
Molecular Weight | 362.40000 |
Exact Mass | 362.15400 |
PSA | 72.94000 |
LogP | 4.62390 |
Storage condition | -20°C |
2-Propenamide (N-(2-amino-4-fluorophenyl)-3-[1-[(2E)-3-phenyl-2-propen-1-yl]-1H-pyrazol-4-yl] |
RGFP966 |